Boston Scientific | BSX - Net Income

Stock Price
59.95
Daily Change
-2.12 -3.42%
Monthly
-4.74%
Yearly
-41.33%
Q2 Forecast
60.74

Boston Scientific reported $1.34B in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Abbott USD 1.08B 699M Mar/2026
AtriCure USD 1.76M 2.02M Dec/2025
Avanos Medical USD -1.3M 100K Dec/2025
Baxter International USD -1.13B 1.08B Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Boston Scientific USD 1.34B 669M Mar/2026
CONMED USD 16.74M 13.88M Dec/2025
Cooper Companies USD 130.8M 46.2M Dec/2025
Danaher USD 1.03B 168M Mar/2026
Dexcom USD 267.3M 16.5M Dec/2025
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
Globus Medical USD 140.59M 21.63M Dec/2025
Illumina USD 334M 184M Dec/2025
Inogen USD -5.96M 373K Sep/2024
Insulet USD 101.6M 14M Dec/2025
Integra LifeSciences USD -1.7M 3.7M Dec/2025
Intuitive Surgical USD 821.5M 26.7M Mar/2026
J&J USD 5.24B 119M Mar/2026
Masimo USD 68.3M 168.7M Dec/2025
Medtronic USD 1.14B 231M Dec/2025
Merit Medical Systems USD 27.76M 4.83M Sep/2025
Stryker USD 849M 10M Dec/2025
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -714.33M 305.44M Dec/2025
Zimmer Biomet Holdings USD 139.3M 91.6M Dec/2025